| アブストラクト | OBJECTIVE: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown notable advancements in managing blood sugar control. Nevertheless, there remains a gap in real-world data regarding the variation in acute pancreatitis (AP) risk among different GLP-1 RAs. Our study aimed to characterize and evaluate AP associated with different GLP-1 RAs (exenatide, lixisenatide, liraglutide, albiglutide, semaglutide, dulaglutide and tirzepatide) in a public adverse events database and to review the relevant case reports. METHODS: We described a case series of patients experiencing AP while on GLP-1 RAs. Additionally, we utilized various algorithms including reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and multi-item gamma Poisson shrinker (MGPS) to analyze data from the Food and Drug Administration's Adverse Event Reporting System (FAERS) regarding suspected adverse events of AP linked to GLP-1 RAs from January 2005 to September 2023. RESULTS: Our case series comprised thirty-nine patients who experienced AP events while on GLP-1 RAs. Within the FAERS database, we retrieved a total of 6,751 individual case safety reports (ICSRs) involving various GLP-1 RAs. The median age of the patients included in our study was 57 years (range: 14-99), with 98.3% of cases classified as serious. Signals indicating AP were observed across all GLP-1 RAs, with particular emphasis on exenatide and liraglutide. CONCLUSION: There is a notable reporting signal of AP associated with all GLP-1 RAs. Healthcare providers must remain vigilant and closely monitor this potentially life-threatening adverse event. |
|---|
| ジャーナル名 | Frontiers in pharmacology |
|---|
| Pubmed追加日 | 2024/11/28 |
|---|
| 投稿者 | Guo, Hui; Guo, Qian; Li, Zhiqiang; Wang, Ze |
|---|
| 組織名 | Department of Pharmacy, Shanxi Cardiovascular Disease Hospital, Taiyuan, Shanxi,;China.;Department of Pharmacy, Second Hospital of Shanxi Medical University, Taiyuan,;Shanxi, China.;Department of Pharmacy, Shanxi Traditional Chinese Medical Hospital, Taiyuan, |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/39605914/ |
|---|
